Follow the latest news on the global One Health Community and join our mailinglist.
Click here to join
Creating a healthy
future for humans,
animals and the
environment.
FROM ONE HEALTH PLATFORM TO GLOBAL ONE HEALTH COMMUNITY
One Health Platform was founded at the third international One Health Congress in Amsterdam in 2015.
Today in 2022, we are proud to announce that the One Health Platform changed its name and extended its vision to an all-encompassing participation, towards a global One Health Community.
OUR OBJECTIVES
Promote a cross-sectoral and collaborative approach to improve the health and well-being of humans, animals and their environments
Foster scientific research into zoonoses and vector-borne infectious diseases
Create synergies and facilitate the sharing of data between researchers
Disseminate and ‘translate’ novel scientific findings to anyone who might benefit from them
Develop the most appropriate communication tools to convey these novel scientific findings and to communicate widely on One Health issues
Training of young researchers
Stakeholder communication
Advocate for a One Health approach
Facilitate the science and policy interface
OUR MOTIVATION
Answering persistent and urgent One Health needs
The creation of an integrated approach to combat different types of health threats by facilitating the network of community stakeholders:
(re-)emerging viruses
antiviral and antimicrobial resistance
bacterial and parasitic infections
Shared concern and understanding that as transborder mobility of humans, animals, food, and feed products increases, so does the threat of the spread of dangerous pathogens and infectious diseases
The need to educate and train the next generation of One Health experts
The need for a framework for information sharing, detecting and mending knowledge gaps and crosssectoral cooperation
Ensure the tradition of the One Health Community in the future
Bio of Ab Osterhaus
Ab Osterhaus
RIZ Hannover, Germany
AB OSTERHAUS, Emeritus Professor Erasmus University Rotterdam The Netherlands, Professor of Wildlife Virology and Virus Discovery, Hannover, Germany
Ab Osterhaus is Director of the Center of Infection Medicine and Zoonosis Research and Guest-Professor at the University of Veterinary Medicine Hannover. He has a long track record as a scientific researcher and Principal Investigator of numerous major scientific projects. He has been Head of the Department of Viroscience at Erasmus MC Rotterdam until 2014, where has run a diagnostic virology lab with more than 40 staff and a research virology lab with over 150 personnel. His research programme follows a novel integrated “viroscience” concept, bringing together world-leading scientists in molecular virology, immunology, epidemiology, pathogenesis, and intervention studies on human and animal virus infections. Among the major accomplishments are the discovery of more than 70 new viruses of humans and animals (e.g. human metapneumovirus, coronaviruses and influenza viruses), elucidation of the pathogenesis of major human and animal virus infections, and development of novel intervention strategies. This has enabled health authorities like the WHO to effectively combat disease outbreaks like SARS and avian influenza. The spin-offs, Viroclinics-DDL, Vironovative and CR2O, together employing more than 500 people, allow effective testing and refining of diagnostic tools and other intervention strategies and illustrate additional societally relevant successes. Professor Osterhaus has acted as mentor for more than 85 PhD students and holds several key patents. He is also the author of more than 1360 papers in peer-reviewed journals, together cited 89,000 times, with an H index 126.
He has been Chair of the European Working Group on Influenza (ESWI) for the past decades, organised numerous international scientific conferences on influenza and other emerging infections, and received numerous prestigious awards. He holds several senior editorships and is Chief Editor of One Health Outlook, a newly established journal of the Springer-Nature group. He is member of the Dutch and German National Academies of Sciences, member of the Belgium Academia of Medicine, and Commander of the Order of the Dutch Lion.
Bio of John Mackenzie
John Mackenzie
Curtin University, Australia
JOHN MACKENZIE, Emeritus Professor, Curtin University, Australia - formerly Professor of Tropical Infectious Diseases
John Mackenzie has an outstanding international reputation in the field of virology and its impacts on public health. He was formerly Professor of Microbiology at The University of Queensland prior to his appointment to Curtin University. He has received a number of international awards for his research, including the inaugural Mahathir Science Award by the Academy of Sciences Malaysia for scientific excellence in recognition of his contributions and innovations towards solving problems in the tropics through science and technology, and the inaugural Premier’s Research Fellowship of the Science Council of Western Australia. He served as Secretary-General of the International Union of Microbiological Societies from 1999 to 2005, and as President of the Australian Society for Microbiology from 1992-1994. He was elected as a Fellow of the Australian Academy of Technological Sciences and Engineering and of the American Academy of Microbiology, and was awarded the decoration of Officer in the Order of Australia for service to microbiology research, particularly as a leading contributor to the understanding of the genetics, pathogenesis and public health implications of viruses, and to education. He led the World Health Organisation (WHO) mission into China seeking information on SARS in 2003 and in 2009-2010, he chaired the International Health Regulations Emergency Committee on Influenza H1N1, and is currently a member of the Emergency Committees on Polio and COVID-19. In 2021, he was appointed to membership of the quadripartite FAO-UNEP-WHO-WOAH One Health High Level Expert Panel. For many years Prof. Mackenzie was a member of the Steering Committee of the Global Outbreak Alert and Response Network and the Asia-Pacific Strategy for Emerging Diseases. With regional colleagues, he co-founded the Asia Pacific Society for Medical Virology. He has published widely on various viruses, especially vector-borne viruses and emerging zoonotic viruses, and has a Google Scholar ’h’ index of 73 from 21,130 citations.
Bio of Clare Taylor
Clare Taylor
Falconry Press, Ireland
Science communicator and journalist
Clare Taylor is a science communicator, writer, editor and policy analyst whose work centres on communicating ideas and policies for a better world. For the past ten years, she has lived in Brussels, working on media, advocacy and communications for sustainable energy and environment-related topics. Her clients include national governments and public agencies, European institutions, NGOs and industry associations. Clare holds a Master of Engineering Science from Oxford University. As a former magazine publisher, she enjoys skillful communications, wicked problems and well-plotted thrillers.
